Overcoming the Immunosuppressive Tumor Microenvironment of Hodgkin Lymphoma Using Chimeric Antigen Receptor T Cells

Ruella, M; Klichinsky, M; Kenderian, SS; Shestova, O; Ziober, A; Kraft, DO; Feldman, M; Wasik, MA; June, CH; Gill, S

Gill, S (reprint author), Smilow Translat Res Ctr, 8-101,3400 Civ Ctr Blvd, Philadelphia, PA 19104 USA.

CANCER DISCOVERY, 2017; 7 (10): 1154

Abstract

Patients with otherwise treatment-resistant Hodgkin lymphoma could benefi t from chimeric antigen receptor T-cell (CART) therapy. However, Hodgkin lym......

Full Text Link